Skip to content
    SLM
    Earnings call· Jun 2026(Q2 FY26)

    SLM Corp SLM

    Jul 23, 2026 Source

    Executive summary

    Sallie Mae Q2 FY26 — Strong Originations and Credit Performance

    Sallie Mae delivered strong Q2 FY26 results, marked by robust loan originations and improved credit quality in new loans, alongside successful loan modification programs. The company is actively preparing for the federal PLUS reform opportunity, with early indicators for new products exceeding expectations. While navigating increased net charge-offs due to changes in recovery strategies, management remains confident in the portfolio's underlying health and expects margin expansion in the second half of the year.

    Highlights

    5
    • Loan originations were $716 million, up nearly 4.5% from the prior year quarter.

    • Origination credit quality improved modestly year-over-year, with the average FICO score increasing from 754 to 755 and cosigner rates remaining strong at 84%.

    • Loan modification programs show sustained success with payment success rates in excess of 80% over 6- and 12-month periods, and over 75% consistently making payments after 3 and 6 months post-program exit.

    • Net interest margin is expected to expand in the second half of the year, with Q2 likely representing the low point for margin.

    • The efficiency ratio of 48.6% reflects the ability to invest meaningfully in future growth while maintaining financial strength.

    Concerns

    4
    • Net charge-offs for the quarter were $113 million, up from $94 million in the prior year quarter, with approximately $16 million attributable to misaligned third-party debt resolution practices.

    • Changes in recovery strategies are expected to create an in-year headroom to potential recoveries of approximately $25 million in 2026.

    • Net interest income decreased by $44 million compared with the prior year quarter.

    • Noninterest expenses were $195 million, up $28 million from the prior year quarter, driven by one-time investments and strategic initiatives.

    Guidance & targets

    5
    CategoryTargetConfidence
    Net charge-off guidance range
    $365 million - $385 million
    high materiality
    High
    Net interest margin (NIM) trajectory
    Expansion to resume, Q2 likely low point
    high materiality
    High
    Share repurchase authorization deployment
    $242 million to be substantially deployed
    high materiality
    High
    Noninterest expense growth rate
    Roughly half the rate of growth from last year to this year
    medium materiality
    Medium
    Balance sheet growth
    Modest growth aspirations for 2027, then low to mid-single-digit rate of growth
    medium materiality
    Medium

    Operational metrics

    6
    Other income
    $45 millionup $16 million from prior year quarter
    Q2 FY26

    Driven by growth in recurring program management fees from strategic partnership and growth in servicing fee revenue.

    Efficiency ratio
    48.6%up 7 percentage points year-over-year
    Q2 FY26

    Reflects ability to invest meaningfully in future growth while continuing to operate from a position of financial strength.

    Total risk-based capital
    13.1%
    Q2 FY26

    Capital position remains solid.

    Common equity Tier 1 capital
    11.8%
    Q2 FY26

    Capital position remains solid.

    Liquidity
    18.6%
    Q2 FY26

    Liquidity position remains solid.

    Fee-based revenue growth
    in excess of 50%
    Year-over-year

    Driven by strategic partnerships, contributing to the top-line denominator of the efficiency ratio.

    Industry KPIs

    9
    MetricValueDetails
    Payment rate>80%%
    Delinquencies3.7%%
    Capital returns$200 millionUSD
    Credit quality mix755FICO score
    Net charge off rate$113 millionUSD
    Loans card receivables$716 millionUSD
    Provision reserve rate5.89%%
    Billed business purchase volume$716 millionUSD
    Net interest margin yield on receivables4.75%%

    Product announcements

    2
    ProductTypeDetails
    Medical, Dental, Law, and MBA productsexpansion
    Parent loanlaunch

    Deals & partnerships

    1
    Undisclosed partnerSecond loan sale partnership

    Selected a partner for bilateral negotiations after a mini-process. Documents are being created and traded, negotiating finer points of economics. Partner expressed strong interest in building capabilities for taking Grad product.

    Risks & headwinds

    3
    Misaligned third-party debt resolution practices2026

    $16 million of the year-over-year increase in net charge-offs ($113 million total) is attributable to these practices. Estimated $25 million potential impact to recoveries in 2026.

    Mitigation: Increased control over post-default recoveries by halting all debt sales and pulling recoveries in-house. Management views this as largely a timing dynamic, expecting internal efforts to equal or exceed recovery levels over time.

    Increased noninterest expensesQ2 FY26

    Noninterest expenses were $195 million, up $28 million from the prior year quarter.

    Mitigation: The majority of this increase was driven by one-time investments and strategic initiatives to support anticipated growth from federal lending reforms. Revenue growth from servicing and recurring program management fees more than offset a significant portion of these investments.

    Net interest margin moderationQ2 FY26

    Net interest margin was 4.75% for the quarter.

    Mitigation: Primarily reflects higher liquidity levels following a loan sale. Management expects margin expansion to resume in the second half of the year as excess liquidity is deployed into new loan originations during peak season, with Q2 likely representing the low point for margin this year.

    What to watch in Q3 FY26

    5

    NIM trajectory

    H2 FY26
    Current4.75%
    TargetCloser to 5% / expansion

    Why it matters

    NIM is a key profitability driver, and its expansion in H2 is crucial for overall financial performance.

    Yes, I think as we deploy the liquidity during the peak season, we'll start to normalize probably closer to our long-term target range of kind of 5%.

    Q&A highlights

    7

    What is the expected NIM trajectory for the second half of the year, given Q2 was expected to be the low point?

    Management expects NIM to normalize closer to the long-term target range of 5% as liquidity is deployed during peak season, though it may not reach the full normal range this year.

    Yes, I think as we deploy the liquidity during the peak season, we'll start to normalize probably closer to our long-term target range of kind of 5%.

    asked by Mark DeVries · answered by Peter Graham

    3 min read6 chapters

    Detailed Narrative

    01

    Federal PLUS Reform Opportunity and New Product Momentum

    The federal PLUS reform has created a significant opportunity for Sallie Mae, with a potential $4.5 billion to $5 billion increase in annual originations over the next several years. The company has successfully launched all planned additional products, features, and functions for the current peak season, including enhancements to medical, dental, law, and MBA products, and the introduction of a new parent loan. Early application and volume trends for these new offerings are at the higher end of expectations or better, reinforcing confidence in 2026 origination estimates and the longer-term opportunity.

    02

    Credit Performance and Strategic Recovery Adjustments

    While net charge-offs increased to $113 million in Q2 FY26, approximately $16 million of this rise is attributed to a specific segment of borrowers engaging with debt resolution providers. Management views this as a timing issue for recoveries rather than a broad credit weakening, and has taken deliberate steps to increase control over post-default recoveries. These actions are expected to create a $25 million headroom to potential recoveries in 2026, but internal efforts are anticipated to equal or exceed this level over time.

    03

    Sustained Success of Loan Modification Programs

    Sallie Mae's loan modification programs continue to demonstrate strong effectiveness, with borrowers in all active modification cohorts achieving payment success rates exceeding 80% over 6- and 12-month periods. Furthermore, over 75% of borrowers who have exited these programs are consistently making payments after 3 and 6 months, surpassing initial expectations. This sustained performance underscores the durability of the portfolio and the efficacy of the company's loss mitigation strategies.

    04

    Net Interest Margin Trajectory and Liquidity Management

    The net interest margin (NIM) moderated to 4.75% in Q2 FY26, primarily due to higher liquidity levels following a loan sale completed in late March. Management anticipates NIM expansion to resume in the second half of the year as this excess liquidity is deployed into new loan originations during the peak season. Q2 is expected to be the low point for NIM this year, with the underlying earnings power of the portfolio remaining strong, supported by disciplined funding and attractive asset yields.

    05

    Strategic Partnerships and Fee-Based Revenue Growth

    The existing strategic partnership with KKR is performing well, with anticipated volumes in line with expectations. Sallie Mae is also progressing with a second loan sale partner, with negotiations for a similar structure expected to close in Q3 or early Q4. These partnerships are driving significant growth in recurring program management fees and servicing fee revenue, which are crucial for offsetting investments and improving the efficiency ratio. Both partners have expressed interest in building capabilities for Grad product, indicating future expansion opportunities.

    06

    Capital Allocation and Shareholder Returns

    Sallie Mae completed a $200 million accelerated share repurchase (ASR) program in Q2 FY26, repurchasing 9.3 million shares. Year-to-date, the company has repurchased approximately 13 million shares, representing 6.5% of shares outstanding at the end of 2025, at an average price of $21.95 per share. With $242 million remaining under the current share repurchase authorization, the company expects to substantially deploy this amount throughout the remainder of the year, demonstrating a disciplined approach to long-term value creation.

    AI-generated summary of the company’s earnings call. Not investment advice.